Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
EDITthis companyEditas Medicine, Inc.	$2.68	-1.14×	6.67×	4.49×	-0.75×	-308.6%	100.0%	-245.2%	-395.0%	-586.6%	-65.6%	-91.2%	2.81×	0.47×	-16.1×	3.54×	0.0%	3	-8.13	2	C
BEAMBeam Therapeutics Inc.	$27.00	-34.22×	2.21×	19.62×	-196.25×	-229.8%	84.0%	-274.6%	-57.2%	-6.5%	-27.4%	-13.1%	0.24×	0.08×	-8.77×	13.09×	0.0%	2	4.01	1	C-
BNTCBenitec Biopharma Inc.	$9.28	-13.65×	3.52×	0×	-8.75×	-68.5%	0.0%	0.0%	0.0%	-25.7%	-28.8%	-2.7%	0×	3.53×	0×	34×	0.0%	1	43.49	2	C+
CRBUCaribou Biosciences, Inc.	$0.46	-1×	1.22×	13.31×	-1.13×	-908.6%	67.3%	-1220.5%	-1327.4%	-121.2%	-89.8%	-75.7%	0.22×	-0.1×	0×	5.71×	0.0%	3	-7.25	2	C
DTILPrecision BioSciences, Inc.	$10.38	-1.17×	0.58×	1.56×	0.68×	-257.3%	100.0%	-152.2%	-133.4%	-49.6%	-35.5%	-123.6%	0.31×	1.93×	-36.67×	13.32×	0.0%	3	-4.84	1	C-
MGXMetagenomi, Inc. Common Stock	$0.73	-0.69×	0.38×	2.39×	-0.72×	-11909.0%	78.9%	-380.9%	-348.5%	-55.4%	-47.0%	-148.3%	0.26×	0.01×	0×	7.22×	0.0%	2	-3.67	2	C
Peer median	—	-1.17×	1.22×	2.39×	-1.13×	-257.3%	78.9%	-274.6%	-133.4%	-49.6%	-35.5%	-75.7%	0.24×	0.08×	0×	13.09×	0.0%	2	-3.67	2	—